Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter.
Biomedical/Life Sciences
Retina Implant AG in Reutlingen, Germany, a medical device company developing sub-retinal implants to help visually impaired people improve their sight, secured $18 million in its second round of equity funding from its existing investors.
CardioFocus in Marlborough, Massachusetts, a developer of a system for laser ablation procedures used in treating irregular heart rhythms known as atrial fibrillation, raised $30.6 million in equity financing from new investors First Alliance & Capital Invest, Fletcher Spaght Ventures, and Manatuck Hill Partners, as well as all previous investors.
NeuroPhage Pharmaceuticals, a drug developer in Cambridge, Massachusetts, raised $12.4 million in a Series B financing led by Mérieux Développement, the health care investment arm of French firm Institut Mérieux, with backing from Irish biopharma company Shire.
Cardiorobotics in Raynham, Massachusetts, a maker of a robotic catheter for heart procedures, raised $6.6 million of equity- and rights-based funding.
Tibion in Sunnyvale, California, a maker of a bionic assist device to help stroke victims recover movement and strength in their legs, collected $10.175 million in venture backing, led by Three Arch Partners and Hambrecht & Quist Capital Management.
Energy and Environment
Aircuity in Newton, Massachusetts, a developer of systems for intelligently controlling air ventilation in commercial buildings, added a $3.5 million equity round.
Powerit Solutions in Seattle, Washington, which provides energy management and conservation for industry clients, captured $5 million in equity financing, led by new investor Black Coral Capital and joined by four repeat investors.
Engineering and Electronics
Achronix a semiconductor company in Santa Clara, California, raised $45 million in a series C equity funding round.
Physical Sciences
Genomatica, a biotechnology company in San Diego, California creating industrial chemicals, raised $45 million in a Series C round of venture equity funding.
Read more: Finance Friday: 25 February 2011
* * *
You must be logged in to post a comment.